Molindone Hydrochloride (CAS 15622-65-8)
QUICK LINKS
Molindone Hydrochloride is a D2DR inhibitor and a MAO inhibitor. Molindone is a dihydroindolone compound. Molindone hydrochloride is the hydrochloride salt of molindone. Its mechanism of action is believed to involve antagonistic activity on D2S, D2L, D5 dopamine, and 5-HT2B serotonin receptors. Molindone hydrochloride at a concentration of 10^-4 M or greater has been found to inhibit the enzyme cardiac adenylate cyclase. Molindone hydrochloride has been found to decrease tryptamine binding sites. Molindone hydrochloride binds more selectively to dopamine receptors than tryptamine or 5-HT receptors. Further more, molindone hydrochloride inhibits type A monoamine oxidase, leading to a substantial increase in the endogenous accumulation rate of tryptamine, significantly surpassing those of dopamine and 5-HT.
Molindone Hydrochloride (CAS 15622-65-8) References
- Tissue distribution of molidone in a multidrug overdose. | Flammia, DD., et al. 2004. J Anal Toxicol. 28: 533-6. PMID: 15516311
- Neuroleptic malignant syndrome possibly caused by molindone hydrochloride. | Gradon, JD. 1991. DICP. 25: 1071-2. PMID: 1803792
- Neuroleptic-induced 'painful legs and moving toes' syndrome: successful treatment with clonazepam and baclofen. | Sandyk, R. 1990. Ital J Neurol Sci. 11: 573-6. PMID: 2081681
- Molindone hydrochloride: a review of laboratory and clinical findings. | Owen, RR. and Cole, JO. 1989. J Clin Psychopharmacol. 9: 268-76. PMID: 2671060
- In vitro and in vivo genotoxicity assessment of the dopamine receptor antagonist molindone hydrochloride. | Krishna, G., et al. 2016. Environ Mol Mutagen. 57: 288-98. PMID: 27040600
- Toxicity assessment of molindone hydrochloride, a dopamine D2/D5 receptor antagonist in juvenile and adult rats. | Krishna, G., et al. 2017. Toxicol Mech Methods. 27: 352-362. PMID: 28142338
- Molindone hydrochloride treatment of hospitalized children with conduct disorder. | Greenhill, LL., et al. 1985. J Clin Psychiatry. 46: 20-5. PMID: 3894338
- Review of clinical and laboratory experiences with molindone hydrochloride. | Claghorn, JL. 1985. J Clin Psychiatry. 46: 30-3. PMID: 3894340
- Bioavailability of oral and intramuscular molindone hydrochloride in schizophrenic patients. | Zetin, M., et al. 1985. Clin Ther. 7: 169-75. PMID: 3986861
- Preformulation studies. I. Molindone hydrochloride. | Dudzinski, J., et al. 1973. J Pharm Sci. 62: 622-4. PMID: 4698984
- Small animal model for evaluating neuroleptic potency. | Rosenberg, JM. and Lau-Cam, CA. 1980. J Pharm Sci. 69: 74-7. PMID: 6101619
- Molindone Hydrochloride in the treatment of aggressive, hospitalized children [proceedings]. | Greenhill, LL., et al. 1981. Psychopharmacol Bull. 17: 125-7. PMID: 7232643
- Long-term study of molindone hydrochloride in chronic schizophrenics. | Kellner, R., et al. 1976. Curr Ther Res Clin Exp. 20: 686-94. PMID: 825355
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Molindone Hydrochloride, 10 mg | sc-207893 | 10 mg | $163.00 |